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The incidence of end-stage renal disease (ESRD) is
increasing worldwide. These increases represent a signif-
icant burden to countries, not only because of the finan-
cial costs of providing ESRD care, but also because of the
significant morbidity and mortality of affected patients.
Therefore, there is a clear, pressing need for the aggres-
sive identification and early treatment of patients with
nephropathy to prevent progression to ESRD.
Most chronic nephropathies lack a specific treatment
and progress relentlessly to ESRD. However, research
has indicated possible preventive methods such as phar-
macologic control of blood pressure, reduction of pro-
teinuria, smoking cessation, tight glucose control for
diabetes, and many other measures that may postpone
dialysis for many patients with chronic nephropathies.
Remission of disease and regression of structural dam-
age to the kidney are the goals to achieve in the
future.
The Second International Conference on New In-
sights in Progression of Chronic Kidney Disease, held
in Barcelona May 8–10, 2005 by the Spanish Society of
Nephrology, discussed several key areas about the pro-
gression of chronic kidney disease: (1) epidemiology and
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the need for an optimal and coordinated management of
chronic kidney disease; (2) factors involved in the pro-
gression of chronic kidney disease such as angiotensin II,
hypoxia, systemic, and glomerular hypertension, calcium
disorders, oxidant stress, anemia, dislipidemia, and so
forth; (3) measures to prevent the progression of chronic
kidney disease including diabetic nephropathy and renal
transplantation; and (4) cost-effective strategies for the
prevention of the progression of renal failure and clinical
benefits of slowing the progression of renal failure.
The summaries of the presentations are highlighted
in the articles that follow. We are grateful to all the
distinguished contributors who accepted our request to
elaborate on their area of expertise both in their presen-
tations at the meeting and in these published proceedings.
The conference and publication of its proceedings were
possible only because Amgen provided technical and fi-
nancial support by an unrestricted educational grant. We
especially thank the secretary’s office of the Spanish So-
ciety of Nephrology for the organization of the event and
the work with the manuscripts. The organizing committee
hopes that these articles will help to define the importance
of the issues.
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